Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 29, 2017 - Issue 4
153
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Application of the ICRP respiratory tract model to estimate pulmonary retention of industrially sampled indium-containing dusts

, , &
Pages 169-178 | Received 06 Feb 2017, Accepted 16 May 2017, Published online: 08 Jun 2017

References

  • Amata A, Chonan T, Omae K, et al. (2015). High levels of indium exposure relate to progressive emphysematous changes: a 9-year longitudinal surveillance of indium workers. Thorax 70:1040–6.
  • Andersen JC, Cropp A, Paradise DC. (2017). Solubility of indium-tin oxide in simulated lung and gastric fluids: pathways for human intake. Sci Total Environ 579:628–36.
  • Badding MA, Fix NR, Orandle MS, et al. (2016). Pulmonary toxicity of indium-tin oxide production facility particles in rats. J Appl Toxicol 36:618–26.
  • Badding MA, Schwegler-Berry D, Park JH, et al. (2015). Sintered indium-tin oxide particles induce pro-inflammatory responses in vitro, in part through inflammasome activation. PLoS One 10:e0124368.
  • Badding MA, Stefaniak AB, Fix NR, et al. (2014). Cytotoxicity and characterization of particles collected from an indium-tin oxide production facility. J Toxicol Environ. Health Part A 77:1193–209.
  • Bertelli L, Melo DR, Lipsztein J, Cruz-Suarez R. (2008). AIDE: internal dosimetry software. Radiat Prot Dosimetry 130:358–67.
  • Castronovo FP Jr, Wagner HN Jr. (1973). Comparative toxicity and pharmacodynamics of ionic indium chloride and hydrated indium oxide. J Nucl Med 14:677–82.
  • Chazel V, Houpert P, Ansoborlo E, et al. (2000). Variation of solubility, biokinetics and dose coefficient of industrial uranium oxides according to specific surface area. Radiat Prot Dosimetry 88:223–31.
  • Choi S, Won YL, Kim D, et al. (2015). Interstitial lung disorders in the indium workers of Korea: an update study for the relationship with biological exposure indices. Am J Ind Med 58:61–8.
  • Choi S, Won YL, Kim D, et al. (2013). Subclinical interstitial lung damage in workers exposed to indium compounds. Ann Occup Environ Med 25:24.
  • Choi S, Won YL, Kim EA. (2015). Effect of respiratory protector intervention among indium reclaiming workers. Am J Ind Med 58:1319–20.
  • Chonan T, Taguchi O, Omae K. (2007). Interstitial pulmonary disorders in indium-processing workers. Eur Respir J 29:317–24.
  • Cummings KJ, Donat WE, Ettensohn DB, et al. (2010). Pulmonary alveolar proteinosis in workers at an indium processing facility. Am J Respir Crit Care Med 181:458–64.
  • Cummings KJ, Nakano M, Omae K, et al. (2012). Indium lung disease. Chest 141:1512–21.
  • Cummings KJ, Virji MA, Park JY, et al. (2016). Respirable indium exposures, plasma indium, and respiratory health among indium-tin oxide (ITO) workers. Am J Ind Med 59:522–31.
  • Cummings KJ, Virji MA, Trapnell BC, et al. (2014). Early changes in clinical, functional, and laboratory biomarkers in workers at risk of indium lung disease. Ann Am Thorac Soc 11:1395–403.
  • de Vocht F, Burstyn I, Sanguanchaiyakrit N. (2015). Rethinking cumulative exposure in epidemiology, again. J Expo Sci Environ Epidemiol 25:467–73.
  • Finch GL, Mewhinney JA, Eidson AF, et al. (1988). In vitro dissolution characteristics of beryllium oxide and beryllium metal aerosols. J Aerosol Sci 19:333–42.
  • Greenhill SR, Kotton DN. (2009). Pulmonary alveolar proteinosis: a bench-to-bedside story of granulocyte-macrophage colony-stimulating factor dysfunction. Chest 136:571–7.
  • Gwinn WM, Qu W, Bousquet RW, et al. (2015). Macrophage solubilization and cytotoxicity of indium-containing particles as in vitro correlates to pulmonary toxicity in vivo. Toxicol Sci 144:17–26.
  • Gwinn WM, Qu W, Shines CJ, et al. (2013). Macrophage solubilization and cytotoxicity of indium-containing particles in vitro. Toxicol Sci 135:414–24.
  • Hamaguchi T, Omae K, Takebayashi T, et al. (2008). Exposure to hardly soluble indium compounds in ITO production and recycling plants is a new risk for interstitial lung damage. Occup Environ Med 65:51–5.
  • Harvey RR, Virji MA, Edwards NT, Cummings KJ. (2016). Comparing plasma, serum and whole blood indium concentrations from workers at an indium-tin oxide (ITO) production facility. Occup Environ Med 73:864–7.
  • Hoet P, De Graef E, Swennen B, et al. (2012). Occupational exposure to indium: what does biomonitoring tell us? Toxicol Lett 213:122–8.
  • Homma S, Miyamoto A, Sakamoto S, et al. (2005). Pulmonary fibrosis in an individual occupationally exposed to inhaled indium-tin oxide. Eur Respir J 25:200–4.
  • Homma T, Ueno T, Sekizawa K, et al. (2003). Interstitial pneumonia developed in a worker dealing with particles containing indium-tin oxide. J Occup Health 45:137–9.
  • ICRP. 1981. International Commission on Radiological Protection. Publication 30 (Part 3): Limits for intakes of radionuclides by workers. Ann ICRP 6(2–3).
  • ICRP. 1994. International Commission on Radiological Protection. Publication 66: Human respiratory tract model for radiological protection Oxford (UK): Pergamon.
  • Iwasawa S, Nakano M, Miyauchi H, et al. (2017). Personal indium exposure concentration in respirable dusts and serum indium level. Ind Health 55:87–90.
  • Jeong J, Kim J, Seok SH, Cho WS. (2016). Indium oxide (In2O3) nanoparticles induce progressive lung injury distinct from lung injuries by copper oxide (CuO) and nickel oxide (NiO) nanoparticles. Arch Toxicol 90:817–28.
  • Kanapilly GM, Raabe OG, Goh CH, Chimenti RA. (1973). Measurement of in vitro dissolution of aerosol particles for comparison to in vivo dissolution in the lower respiratory tract after inhalation. Health Phys 24:497–507.
  • Kitamura T, Tanaka N, Watanabe J, et al. (1999). Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med 190:875–80.
  • Kriebel D, Checkoway H, Pearce N. (2007). Exposure and dose modelling in occupational epidemiology. Occup Environ Med 64:492–8.
  • Liao YH, Yu HS, Ho CK, et al. (2004). Biological monitoring of exposures to aluminium, gallium, indium, arsenic, and antimony in optoelectronic industry workers. J Occup Environ Med 46:931–6.
  • Lim CH, Han JH, Cho HW, Kang M. (2014). Studies on the toxicity and distribution of indium compounds according to particle size in Sprague-Dawley rats. Toxicol Res 30:55–63.
  • Lippman M. 1999. Rationale for particle size-selective aerosol sampling. In: Vincent J, ed. Particle size-selective sampling for particulate air contaminants. Cincinnati, OH: ACGIH, 3–28.
  • Lison D, Laloy J, Corazzari I, et al. (2009). Sintered indium-tin-oxide (ITO) particles: a new pneumotoxic entity. Toxicol Sci 108:472–81.
  • Liu HH, Chen CY, Chen GI, et al. (2012). Relationship between indium exposure and oxidative damage in workers in indium tin oxide production plants. Int Arch Occup Environ Health 85:447–53.
  • Liu HH, Chen CY, Lan CH, et al. (2016). Effects of a powered air-purifying respirator intervention on indium exposure reduction and indium related biomarkers among ITO sputter target manufacturing workers. J Occup Environ Hyg 13:346–55.
  • Miller FJ, Kaczmar SW, Danzeisen R, Moss OR. (2013). Estimating lung burdens based on individual particle density estimated from scanning electron microscopy and cascade impactor samples. Inhal Toxicol 25:813–27.
  • Miyaki K, Hosoda K, Hirata M, et al. (2003). Biological monitoring of indium by means of graphite furnace atomic absorption spectrophotometry in workers exposed to particles of indium compounds. J Occup Health 45:228–30.
  • Miyauchi H, Minozoe A, Tanaka S, et al. (2012). Assessment of workplace air concentrations of indium dust in an indium-recycling plant. J Occup Health 54:103–11.
  • Nagano K, Gotoh K, Kasai T, et al. (2011). Two- and 13-week inhalation toxicities of indium-tin oxide and indium oxide in rats. J Occup Health 53:51–63.
  • Nagano K, Nishizawa T, Eitaki Y, et al. (2011). Pulmonary toxicity in mice by 2- and 13-week inhalation exposures to indium-tin oxide and indium oxide aerosols. J Occup Health 53:234–9.
  • Nakano M, Omae K, Tanaka A, et al. (2009). Causal relationship between indium compound inhalation and effects on the lungs. J Occup Health 51:513–21.
  • Nakano M, Omae K, Uchida K, et al. (2014). Five-year cohort study: emphysematous progression of indium-exposed workers. Chest 146:1166–75.
  • Nakano M, Tanaka A, Hirata M, et al. (2016). An advanced case of indium lung disease with progressive emphysema. J Occup Health 58:477–81.
  • Omae K, Nakano M, Tanaka A, et al. (2011). Indium lung-case reports and epidemiology. Int Arch Occup Environ Health 84:471–7.
  • Smith TJ. (1992). Occupational exposure and dose over time: limitations of cumulative exposure. Am J Ind Med 21:35–51.
  • Stefaniak AB, Guilmette RA, Day GA, et al. (2005). Characterization of phagolysosomal simulant fluid for study of beryllium aerosol particle dissolution. Toxicol In Vitro 19:123–34.
  • Tanaka A, Hirata M, Homma T, Kiyohara Y. (2010). Chronic pulmonary toxicity study of indium-tin oxide and indium oxide following intratracheal instillations into the lungs of hamsters. J Occup Health 52:14–22.
  • Tanaka A, Hirata M, Omura M, et al. (2002). Pulmonary toxicity of indium-tin oxide and indium phosphide after intratracheal instillations into the lung of hamsters. J Occup Health 44:99–102.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.